Immunic
IMUX
54 hedge funds and large institutions have $2.39M invested in Immunic in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 23 closing their positions.
186% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 7
0.03% less ownership
Funds ownership: 0.08% → 0.05% (-0.03%)
13% less funds holding
Funds holding: 62 → 54 (-8)
35% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 23
88% less call options, than puts
Call options by funds: $76K | Put options by funds: $659K
97% less capital invested
Capital invested by funds: $95M → $2.39M (-$92.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$5.12M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.16M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.15M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.7M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$21.1M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$7.5M |
| 3 |
AG
Artal Group
Luxembourg
|
-$6.85M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.59M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.24M |
IMUX Hedge Fund Activity: Q3 2018 in Review
54 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Immunic (IMUX) for Q3 2018, worth a combined $2.39M — down 97% from $95M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of IMUX and 15 opened new positions — a net loss of 8 holders — while 7 trimmed existing stakes and 20 added.
The largest buyer was Millennium Management, adding an estimated $5.12M. The largest seller was Victory Capital Management, exiting entirely with an estimated $21.1M sold.
- 54 institutional investors held Immunic (IMUX) as of Q3 2018, down from 62 in Q2 2018.
- Funds reported $2.39M of Immunic stock for Q3 2018, down 97% quarter-over-quarter.
- 15 funds opened new Immunic positions in Q3 2018 and 23 closed out, a net change of -8 holders.
- The largest Immunic buyer in Q3 2018 was Millennium Management, an estimated $5.12M added.
- The largest Immunic seller in Q3 2018 was Victory Capital Management, an estimated $21.1M sold.
Based on aggregated 13F filings for Q3 2018.